Introduction
============

According to the latest National Comprehensive Cancer Network (NCCN) guidelines either suspected or histologically defined gastric gastrointestinal stromal tumors (GISTs) larger than 20 mm in diameter should be removed with histologically negative margines [@JR1832-1] . Furthermore, patients with suspected or defined GISTs less then 20 mm in diameter which display high-risk endoscopic ultrasound (EUS) features (i. e. irregular borders, cystic spaces, ulcerations, echogenic foci and heterogeneity) should undergo complete surgical resection. Given the limited intramural extension of GISTs, laparoscopic segmental or wedge resection is currently regarded as the gold standard for their treatment [@JR1832-1] . However, in recent years, a novel minimally invasive technique called exposed endoscopic full-thickness resection (Eo-EFTR) without laparoscopic assistance has emerged as a promising approach with good efficacy and safety in the resection of gastric submucosal tumors (G-SMTs) originating from the muscularis propria (MP) through natural orifice transluminal endoscopic surgery (NOTES) [@JR1832-2] [@JR1832-3] [@JR1832-4] [@JR1832-5] [@JR1832-6] .

Endoscopic full-thickness resection was first described in 1998 by Suzuki et al [@JR1832-7] . In 2001, the same group reported the effectiveness of endoscopic full-thickness resection (EFTR) with the use of a ligation device for the treatment of two rectal and one duodenal neuroendocrine tumors in humans [@JR1832-8] . A few years later, Ikeda et al. reported EFTR using the ESD technique on a porcine stomach [@JR1832-9] and Zhou et al *.* translated this technique into clinical practice (26 cases of gastric SMTs) [@JR1832-10] .

The mainstay of Eo-EFTR is a safe wall defect closure after excision to prevent peritonitis and further surgical interventions. Currently, this is mainly achieved by use of standard through-the-scope clips [@JR1832-10] or clips combined with endoloops [@JR1832-11] [@JR1832-12] , whereas defect closure by use of over-the-scope clips or endoscopic suturing devices has been reported in only a few cases [@JR1832-13] [@JR1832-14] [@JR1832-15] [@JR1832-16] [@JR1832-17] [@JR1832-18] [@JR1832-19] .

The Eo-EFTR procedure is described as follows [@JR1832-10] : (A) submucosal injection followed by precutting the mucosal and submucosal layer around the lesion by standard ESD technique; (B) full-thickness resection of the lesion, including the serosal layer, and (C) creation of "active perforation" after sucking away intraluminal fluid; (D) gastric wall defect closure by the use of clips or other suturing techniques.

pplication of Eo-EFTR to MP-originating G-SMTs has been partially limited by the technical difficulty involved and safety concerns, especially regarding effective defect closure achievement. Despite these limitations, an increasing number of series have recently reported on application of Eo-EFTR to gastric SMTs. However, the majority of them were retrospective and single-center studies, including only a relatively small number of cases [@JR1832-2] [@JR1832-3] [@JR1832-4] [@JR1832-5] [@JR1832-6] . When considering the relatively low frequency of major adverse events (AEs) or surgical conversions due to either AEs or technical unfeasibility, such small sample sizes prevent reliable estimates of the efficacy and safety of gastric Eo-EFTR. The aim of this systematic review was to assess the efficacy and safety of gastric Eo-EFTR without laparoscopic assistance.

Material and methods
====================

Analysis and generation of inclusion criteria were performed according to the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) recommendation [@JR1832-20] .

Eligibility criteria
--------------------

All original articles published from January 1998 (the year Eo-EFTR was first described) to November 2019 in which Eo-EFTR without laparoscopic assistance was performed for lesions of the stomach were reviewed. Exclusion criteria included publications that exist only as an abstract, case reports, case series (\< 10 cases), non-human studies, review articles, position papers, editorials, commentaries, and book chapters. In case of studies from same institute and suspicion of cohort overlapping, only the study which included the highest number of patients over the longest time interval was considered for inclusion, while other were excluded in order to avoid data duplication.

Information sources
-------------------

One investigator (AM) performed a detailed literature search of the PubMed (MEDLINE) and EMBASE electronic databases for the period 1998--2019.The search strategy was limited to articles on human subjects and written in English. The adopted search queries were as follows: "endoscopic full thickness resection" AND ("stomach" OR "gastric") AND (("1998/01/01"\[PDat\]: "2019/11/30" \[PDat\]) AND humans\[Mesh\] AND english\[lang\]) for MEDLINE; ('endoscopic full thickness resection'/exp OR 'endoscopic full thickness resection') AND ('stomach'/exp OR 'stomach' OR 'gastric') AND \[english\]/lim AND \[humans\]/lim AND \[embase\]/lim AND 1--1--1998/sd NOT 1--12--2019/sd for EMBASE. The reference lists of review articles and pertinent identified studies were carefully hand-searched by one author (AM) to identify any additional relevant studies that may have been missed by the use of the above-mentioned search strategy.

Study selection
---------------

Records identified by our search strategy were screened by two independent researchers (AM, AG) according to the title and abstract. Eligibility criteria were assessed by the reviewers. The full text was retrieved and reviewed for all records that showed even a remote potential for inclusion in final analysis.

Data collection process and list of items
-----------------------------------------

Data extraction was performed by two independent researchers (AM, AG) by the use of predefined data extraction forms. A third author (MT) arbitrated in the event of any lack of agreement. From each record, researchers independently extracted the following information: first author, year of publication, country where the study was performed, type of study (single- or multicenter), study design, number of patients, indication for Eo-EFTR, number of Eo-EFTR-treated lesions, tumor gastric site (cardia/fundus/body/antrum), mean tumor size (cm), depth of invasion of the tumor evaluated by preoperative EUS, type of wall defect closure technique, histopathological diagnosis (GIST/leiomyoma/schwannoma/others), mean follow-up period (months), the primary and secondary endpoints.

Summary measures
----------------

Primary endpoints of this study were as follows:

1.  per-lesion rate of Eo-EFTR complete resection (i. e. en bloc resection with negative vertical and lateral resection margins at histology: R0 resection);

2.  per-lesion rate of surgical conversion (i. e. due to either Eo-EFTR failure or adverse events).

Secondary endpoints included:

1.  per-lesion rate of overall Eo-EFTR-related major adverse events (i. e. delayed bleeding, delayed perforation, peritonitis, abdominal abscess and/or abdominal infection);

2.  per-lesion rate of delayed bleeding;

3.  per-lesion rate of delayed perforation;

4.  per-lesion rate of peritonitis, abdominal abscess and/or abdominal infection;

5.  per-lesion rate of successful Eo-EFTR (i. e. complete resection of the tumor and effective endoscopic defect closure with neither delayed perforation occurrence nor surgical conversion need).

In case of incomplete data presentation and/or apparent conflict or inconsistency in the article attempts were made to contact authors. However, additional data were required only when involving the primary endpoints.

Descriptive statistics were used to report findings. Integrated data was provided as a mean value of the data in each study.

Quality of studies
------------------

Quality of included studies was assessed by using the Newcastle-Ottawa scale for cohort studies [@OR1832-21] . For each study were assessed: representativeness of the exposed cohort, ascertainment of exposure, demonstration outcome of interest not present at start, assessment of outcome, adequate length of follow-up. Selection of the non-exposed cohort was not considered because in all the included studies, cohort not exposed to endoscopic resection was not present. In studies comparing Eo-EFTR and other resection techniques comparability of cohorts was not considered, because not pertinent to the present review.

Results
=======

Study selection
---------------

A total of 343 records were identified by the Medline and Embase search. 67 duplicates were excluded, 226 non-pertinent records were excluded and 50 full-text articles were considered for inclusion. Of these potential papers, 35 were excluded ( [Table 1](#TB1832-1){ref-type="table"} ). Finally, 15 original articles were included in final analysis [@JR1832-10] [@JR1832-11] [@JR1832-12] [@JR1832-22] [@JR1832-23] [@JR1832-24] [@JR1832-25] [@JR1832-26] [@JR1832-27] [@JR1832-28] [@JR1832-29] [@JR1832-30] [@JR1832-31] [@JR1832-32] [@JR1832-33] . A flow diagram summarizing the procedure of study selection is presented in [Fig. 1](#FI1832-1){ref-type="fig"} .

###### Excluded studies and reasons for exclusion.

  First author   Journal                         Date   Exclusion
  -------------- ------------------------------- ------ ------------------------------------------------------------------------
  Li             Surg Endosc                     2019   No main outcome data
  Li             Surg Endosc                     2019   No data distinction between EFTR and ESE
  Inayat         Clin Endosc                     2019    \< 10 cases
  Guo            Gastroenterol Res Pract         2019   Data duplication; no data distinction between EFTR and ESD, STER, LECS
  Zhang          Endosc Int Open                 2019   No main outcome data; no data distinction between EFTR and ESD
  Huang          Rev Assoc Med Bras (1992)       2018   Duplication
  Zhang          World J Gastroenterol           2018   No main outcome data
  Shi            Laparoendosc Adv Surg Tech A    2018   No main outcome data
  Li             Endoscopy                       2018   Neo-EFTR
  Duan           Rev Esp Enferm Dig              2018   No main outcome data
  Andalib        Surg Endosc                     2018    \< 10 cases
  Zhang          Surg Endosc                     2018   EMSLD
  Yu             Surg Endosc                     2017   No main outcome data
  Tan            Surg Endosc                     2017   No main outcome data
  Gluzman        Transl Gastroenterol Hepatol    2017    \< 10 cases
  Hu             Medicine (Baltimore)            2017   Data duplication
  Zhang          Saudi J Gastroenterol           2017   No main outcome data; no data distinction between EFTR and ESD
  Kratt          Gastrointest Endosc             2016   Case report; Neo-EFTR
  Cai            Surg Endosc                     2016   No main outcome data
  Tang           Surg Endosc                     2016   No main outcome data
  Modayil        Gastrointest Endosc Clin N Am   2016   No data distinction between EFTR and STER
  Guo            Surg Endosc                     2015   Data duplication
  Schmidt        Endoscopy                       2015   Editorial
  Fähndrich      Endoscopy                       2015   Neo-EFTR
  Huang          World J Gastroenterol           2014   Data duplication
  Stavropoulos   Gastrointest Endosc             2014   Case report
  Huang          World J Gastroenterol           2014   Data duplication
  Zhang          Surg Endosc                     2014   No data distinction between EFTR and ESD
  Mori           Gastrointest Endosc             2014   Case report
  Zhang          Chin Med J (Engl)               2013   Data duplication
  Qin            Endoscopy                       2013   Comment
  Huang          World J Gastroenterol           2012   No main outcome data
  Kopelman       Gastrointest Endosc             2012   Review
  Cho            Endoscopy                       2011   Laparoscopic assistance
  Kantsevoy      Gastrointest Endosc             2006   Editorial

EFTR, endoscopic full-thickness resection; ESE, endoscopic submucosal excavation; ESD, endoscopic submucosal dissection; STER, submucosal tunneling endoscopic resection; LECS, laparoscopic and luminal endoscopic cooperative surgery; Neo-EFTR, not exposed endoscopic full-thickness resection; EMSLD, endoscopic mucosa-sparing lateral dissection.

![ Flow chart of the study selection procedure.](10-1055-a-1198-4357-i1832ei1){#FI1832-1}

Study characteristics
---------------------

All of the included articles were performed in Asian countries (14 in China, 1 in Japan). With the exception of one multicenter study, all of the remnant were single-center studies. All but one prospective study were retrospective. The enrollment period ranged widely, from 2007 to 2017. The characteristics of the studies included in final analysis are summarized in [Table 2](#TB1832-2){ref-type="table"} .

###### Characteristics of the included studies.

  Reference                   Study design    Country   Study type     Enrollment period
  --------------------------- --------------- --------- -------------- -------------------
  Zhou et al. [@JR1832-10]    Retrospective   Asian     Monocentric    2007--2009
  Shi et al. [@JR1832-11]     Retrospective   Asian     Monocentric    2011--2012
  Ye et al. [@JR1832-12]      Retrospective   Asian     Monocentric    2009--2012
  Feng et al. [@JR1832-22]    Retrospective   Asian     Monocentric    2009--2012
  Dong et al. [@JR1832-23]    Retrospective   Asian     Monocentric    2011--2012
  Wu et al. [@JR1832-24]      Retrospective   Asian     Monocentric    2009--2014
  Yang et al. [@JR1832-25]    Retrospective   Asian     Monocentric    2012--2014
  Lu et al. [@JR1832-26]      Retrospective   Asian     Monocentric    2013--2015
  Shi et al. [@JR1832-27]     Retrospective   Asian     Multicentric   2014--2015
  Hu et al. [@JR1832-28]      Prospective     Asian     Monocentric    2015--2016
  Sun et al. [@JR1832-29]     Retrospective   Asian     Monocentric    2009--2016
  Abe et al. [@JR1832-30]     Retrospective   Asian     Monocentric    2007--2017
  Wu et al. [@JR1832-31]      Retrospective   Asian     Monocentric    2016--2017
  Zhang et al. [@JR1832-32]   Retrospective   Asian     Monocentric    2013--2017
  Li et al. [@JR1832-33]      Retrospective   Asian     Monocentric    2014--2016

Clinical characteristics
------------------------

A total of 750 patients were enrolled in the selected studies. The number of patients enrolled in each study ranged from 10 to 192, with a median of 48. The weighted average of the means age across the included studies was 55.9 years (range 44.3--66.5 years). The median of the male sex rate was 43 % (range 23 %--60 %) ( [Table 3](#TB1832-3){ref-type="table"} ).

###### Demographics of the included studies.

  Reference                   Patients, n   Mean age (range), years   Sex male, %
  --------------------------- ------------- ------------------------- -------------
  Zhou et al. [@JR1832-10]     26           66.5 ± 6.9 (30--76)       58
  Shi et al. [@JR1832-11]      20           47 ± 8.6 (32--63)         25
  Ye et al. [@JR1832-12]       51           50 (34--74)               43
  Feng et al. [@JR1832-22]     48           56.8 ± 11.2 (27--75)      52
  Dong et al. [@JR1832-23]     10           54 ± 11.9 (32--74)        40
  Wu et al. [@JR1832-24]       50           44.3 (--)                 56
  Yang et al. [@JR1832-25]     41           53.9 ± 14.1 (--)          32
  Lu et al. [@JR1832-26]       62           56.4 (37--79)             58
  Shi et al. [@JR1832-27]      68           61 (38--73)               60
  Hu et al. [@JR1832-28]       13           62 (38--70)               23
  Sun et al. [@JR1832-29]      69           56.6 ± 8.6 (38--77)       36
  Abe et al. [@JR1832-30]      14           --                        --
  Wu et al. [@JR1832-31]       25           59 ± 9 (-)                44
  Zhang et al. [@JR1832-32]    61           --                        --
  Li et al. [@JR1832-33]      192           58.9 ± 9.8 (27--85)       35

Overall, 750 gastric lesions were Eo-EFTR-treated in the included studies. The weighted average of the means tumor size was 2.04 cm (range 1.30--3.40 cm). The clinical indication for Eo-EFTR was MP-originating G-SMT, MP-originating gastric GIST and G-SMT with non-specified layer of origin in 10, 3 and 2 studies, respectively. The weighted average of the mean operation times was 67.5 minutes (range 31--128.7 minutes). As for the histopathological diagnosis of the Eo-EFTR resected gastric lesions, 488 were GISTs, 113 were leiomyomas, 8 were schwannomas and 16 were other types of tumors.

Histological diagnosis was not available in 50 of 750 G-SMTs [@JR1832-24] . Across two studies reporting 75 of 750 G-SMTs, data concerning final histopathological diagnosis could not be extrapolated from data coming from other resection techniques [@JR1832-30] [@JR1832-32] . Clinicopathological and technical characteristics of the included studies are summarized in [Table 4](#TB1832-4){ref-type="table"} .

###### Clinicopathological and technical characteristics of the included studies.

  Reference                   Lesions, n   Mean tumor size (range), cm   Location (cardia/antrum/body/fundus)   Layer of origin   Histological diagnosis (GIST/leiomyoma/schwannoma/others)   Countertraction method use                                                     Suture technique                  Mean procedure time (range), min
  --------------------------- ------------ ----------------------------- -------------------------------------- ----------------- ----------------------------------------------------------- ------------------------------------------------------------------------------ --------------------------------- --------------------------------------------
  Zhou et al. [@JR1832-10]     26          2.80 ± 1.30 (1.20--4.50)      0/0/14/12                              MP                16/6/1/3                                                    no                                                                             Clips                             105 (60--145)
  Shi et al. [@JR1832-11]      20          1.47 ± 0.87 (0.40--3.00)      0/1/7/12                               MP                12/4/2/2                                                    no                                                                             EMCIS                             --
  Ye et al. [@JR1832-12]       51          2.40 ± 0.73 (1.30--3.50)      0/1/22/28                              MP                30/21/0/0                                                   no                                                                             Clips and endoloop                52 (30--125)
  Feng et al. [@JR1832-22]     48          1.59 ± 1.01 (0.50--4.80)      0/1/7/40                               MP                43/4/1/0                                                    no                                                                             Clips                             59.7 (30--270)
  Dong et al. [@JR1832-23]     10          1.65 ± 0.59 (0.80--2.50)      1/1/1/7                                MP                10/0/0/0                                                    no                                                                             Clips                             120 (60--180)
  Wu et al. [@JR1832-24]       50          3.40 ± 0.83 (2.50--5.00)      0/13/23/14                             MP                --                                                          no                                                                             Clips                             85 (55--155)
  Yang et al. [@JR1832-25]     41          1.63 ± 5.89 (--)              0/3/25/13                              --                33/4/1/3                                                    no                                                                             Clips (n = 35); OTSC (n = 6)      78.8 (--)
  Lu et al. [@JR1832-26]       62          2.23 ± 1.80 (0.60--6.00)      0/0/29/33                              --                44/17/1/0                                                   not-assisted (n = 30) vs thread-with-clip (n = 21) vs loop-assisted (n = 11)   Clips                             85 (40--180) vs 45 (25--90) vs 40 (30--75)
  Shi et al. [@JR1832-27]      68          2.60 ± 0.50 (2.00--3.50)      0/0/0/68                               MP                68/0/0/0                                                    no                                                                             Clips and endoloops               41 (23--118)
  Hu et al. [@JR1832-28]       13          1.50 ± 1.00 (0.50--3.50)      0/0/2/11                               MP                11/2/0/0                                                    no                                                                             GAL                               43.5 (20--80)
  Sun et al. [@JR1832-29]      69          2.25 ± 1.40 (0.60--6.00)      3/9/17/40                              MP                59/7/1/2                                                    no                                                                             Clips or clips and endoloops      128.7 (17--600)
  Abe et al. [@JR1832-30]      14                                        --                                     MP                --                                                          no                                                                             Clips                             --
  Wu et al. [@JR1832-31]       25          1.70 ± 1.00 (0.50--4.50)      0/0/7/18                               MP                21/2/0/2                                                    no                                                                             p-EPSS                            31 (--)
  Zhang et al. [@JR1832-32]    61          --                            --                                     MP                --                                                          no                                                                             Clips or nylon rope purse         --
  Li et al. [@JR1832-33]      192          1.30 ± 9.8 (0.20--7.00)       0/0/0/192                              MP                141/46/1/4                                                  not-assisted (n = 128) vs DFC-assisted (n = 64)                                clips (n = 90); EMCIS (n = 102)   54.2 (--) vs 44.2 (--)

GIST, gastrointestinal stromal tumor; MP, muscularis propria; EMCIS, endoloop and metallic clip interrupted-suture; OTSC, over-the-scope clip; GAL, grasp-and-loop; p-EPSS, prepurse-string suture; DFC, dental floss and a hemoclip.

Outcomes
--------

Results and information on post-Eo-EFTR follow-up of the included studies are reported in [Table 5](#TB1832-5){ref-type="table"} and [Table 6](#TB1832-6){ref-type="table"} , respectively.

###### Success and major adverse event rate of exposed endoscopic full-thickness resection (Eo-EFTR).

  Reference                   Lesions, n   Complete resection   Surgical conversion   Successfull Eo-EFTR   Major AEs   Peritonitis, abdominal abscess or infection   Delayed perforation   Delayed bleeding
  --------------------------- ------------ -------------------- --------------------- --------------------- ----------- --------------------------------------------- --------------------- ------------------
  Zhou et al. [@JR1832-10]     26           26                  0                      26                   0           0                                             0                     0
  Shi et al. [@JR1832-11]      20           20                  0                      20                   0           0                                             0                     0
  Ye et al. [@JR1832-12]       51           50                  1                      50                   0           0                                             0                     0
  Feng et al. [@JR1832-22]     48           48                  0                      48                   0           0                                             0                     0
  Dong et al. [@JR1832-23]     10           10                  0                      10                   1           1                                             0                     0
  Wu et al. [@JR1832-24]       50           50                  0                      50                   0           0                                             0                     0
  Yang et al. [@JR1832-25]     41           41                  0                      41                   0           0                                             0                     0
  Lu et al. [@JR1832-26]       62           61                  0                      61                   0           0                                             0                     0
  Shi et al. [@JR1832-27]      68           68                  0                      68                   1           0                                             0                     1
  Hu et al. [@JR1832-28]       13           13                  0                      13                   0           0                                             0                     0
  Sun et al. [@JR1832-29]      69           69                  0                      68                   4           2                                             1                     1
  Abe et al. [@JR1832-30]      14           14                  3                      11                   0           0                                             0                     0
  Wu et al. [@JR1832-31]       25           25                  0                      25                   0           0                                             0                     0
  Zhang et al. [@JR1832-32]    61           59                  2                      59                   6           4                                             0                     2
  Li et al [@JR1832-33]       192          187                  0                     187                   0           0                                             0                     0

AEs, adverse events.

###### Follow-up data after exposed endoscopic full-thickness resection (Eo-EFTR) and post-Eo-EFTR recurrence.

  Reference                   Complete resection, n   Mean follow-up (range), months   Recurrence, n
  --------------------------- ----------------------- -------------------------------- ---------------
  Zhou et al. [@JR1832-10]     26                     8 (6--24)                        0
  Shi et al. [@JR1832-11]      20                     6,8 (2--13)                      0
  Ye et al. [@JR1832-12]       50                     22.4 (1--48)                     0
  Feng et al. [@JR1832-22]     48                     -- (2--24)                       0
  Dong et al. [@JR1832-23]     10                     12.3 (4--20)                     0
  Wu et al. [@JR1832-24]       50                     1 (1--1)                         0
  Yang et al. [@JR1832-25]     41                     --                               --
  Lu et al. [@JR1832-26]       61                     7,6 ( 2--24)                     0
  Shi et al. [@JR1832-27]      68                     7 (3--13)                        0
  Hu et al. [@JR1832-28]       13                     5 (1--15)                        0
  Sun et al. [@JR1832-29]      69                     26 (7--84)                       0
  Abe et al. [@JR1832-30]      14                     --                               0
  Wu et al. [@JR1832-31]       25                     7 (1--11)                        0
  Zhang et al. [@JR1832-32]    59                     --                               0
  Li et al. [@JR1832-33]      187                     35 (20--50)                      0

### Primary outcomes

Forteen studies including 750 gastric lesions provided information on the complete resection rate rate (i. e. en bloc resection with negative vertical and lateral resection margins at histology). The per-lesion rate of complete resection was 98.8 %. In addition, 15 studies including 750 lesions provided information on the surgical conversion rate (i. e. due to either Eo-EFTR failure or AEs). The per-lesion rate of surgical conversion was 0.8 %. Conversion to surgery was reported in three studies [@JR1832-12] [@JR1832-30] [@JR1832-32] , who described one, three, and two cases of surgical conversions, respectively. Among the six cases of surgical conversion reported across the included studies, laparoscopic surgery was performed in all cases. Conversion to laparoscopy was performed because of difficulty in endoscopic closure of the wall defect in three cases [@JR1832-30] , whereas intraprocedural tumor fall into the peritoneal cavity [@JR1832-12] , large size and hardness of the tumor [@JR1832-32] and difficulty of tumor dissection [@JR1832-32] were the cause of laparascopic conversion in the remnant three cases, respectively.

### Secondary outcomes

Fifteen studies provided information on Eo-EFTR-related major AEs (i. e. delayed bleeding, delayed perforation, peritonitis, abdominal abscess and/or abdominal infection). The per-lesion reate of overall major AEs was 1.6 %. The per-lesion rate of delayed bleeding was 0.5 %. In all cases, delayed bleeding was resolved with endoscopic and conservative treatments, without requiring surgical intervention [@JR1832-27] [@JR1832-29] [@JR1832-32] .

The per-lesion rate of delayed perforation was 0.1 %.

Only the study from Sun et al. [@JR1832-29] reported one case of delayed perforation out of 69 Eo-EFTRs performed (1.45 %). The size of the Eo-EFTR treated G-SMT was 6 cm and the large wall defect was not easily closed, requiring an operative time of around 600 minutes. A percutaneous endoscopic gastrostomy was performed and the wall defect was efficiently closed with additional clips after the edema disappeared. Notably, in this study post-Eo-EFTR defect closure was performed by the use of standard clips only.

The per-lesion rate of peritonitis, abdominal abscess and/or abdominal infection was 0.9 %.

Three studies reported the occurrence of peritonitis, abdominal abscess and/or abdominal infection. Dong et al *.* [@JR1832-23] reported one case of peritonitis out of 10 Eo-EFTR performed (10 %). Sun et al *.* [@JR1832-29] reported the occurrence of peritonitis in two patients (2/69; 2.9 %), whereas another study reported four cases of abdominal infection (4/61; 6.6 %) [@JR1832-32] . In all cases, conservative treatment was effective with no need of surgical intervention. Of note, within the three studies reporting the post-operative occurrence of peritonitis, abdominal abscess and/or abdominal infection post-Eo-EFTR defect closure was performed by the use of standard clips only [@JR1832-23] , standard clips or clips combined with endoloop in case of defect size larger then the width of the open clip [@JR1832-29] and standard clips or nylon rope purse [@JR1832-32] .

Furthermore, Zhang et al. did not report routine use of perioperative antibiotics and intra-procedural capnoperitoneum management by use of percutaneously inserted angiocatheter [@JR1832-32] .

Finally, the per-lesion rate of successful Eo-EFTR (i. e. complete resection of the tumor and effective endoscopic defect closure with neither delayed perforation occurrence nor surgical conversion need) was 98.3 %.

No cases of recurrent tumors or mortality related to the Eo-EFTR procedure were observed in any of the included studies.

Risk of bias in individual studies
----------------------------------

All selected studies were critically appraised for potential bias in relation to the outcomes of interest. No major selection bias was identified. The risk of bias was considered small in 12 studies with a quality score = 6 and moderate in 3 studies having a quality score = 4 ( [Table 7](#TB1832-7){ref-type="table"} ).

###### Risk of bias in the included individual studies, according to the Newcastle-Ottawa Scale.

  Reference                   A. Selection   B. Comparability   C. Outcome   Total score                     
  --------------------------- -------------- ------------------ ------------ ------------- ----- --- --- --- ---
  Zhou et al. [@JR1832-10]    A              N/A                A            A             N/A   A   A   A   6
  Shi et al. [@JR1832-11]     A              N/A                A            A             N/A   A   A   A   6
  Ye et al. [@JR1832-12]      A              N/A                A            A             N/A   A   A   A   6
  Feng et al. [@OR1832-21]    A              N/A                A            A             N/A   A   A   A   6
  Dong et al. [@JR1832-22]    A              N/A                A            A             N/A   A   A   A   6
  Wu et al. [@JR1832-23]      A              N/A                A            A             N/A   A   A   A   6
  Yang et al. [@JR1832-24]    A              N/A                A            A             N/A   A   B   B   4
  Lu et al. [@JR1832-25]      A              N/A                A            A             N/A   A   A   A   6
  Shi et al. [@JR1832-26]     A              N/A                A            A             N/A   A   A   A   6
  Hu et al. [@JR1832-27]      A              N/A                A            A             N/A   A   A   A   6
  Sun et al. [@JR1832-28]     A              N/A                A            A             N/A   A   A   A   6
  Abe et al. [@JR1832-29]     A              N/A                A            A             N/A   A   B   B   4
  Wu et al. [@JR1832-30]      A              N/A                A            A             N/A   A   A   A   6
  Zhang et al. [@JR1832-31]   A              N/A                A            A             N/A   A   B   B   4
  Li et al. [@JR1832-32]      A              N/A                A            A             N/A   A   A   A   6

**A. Selection** 1. Representativeness of the exposed cohort--A: selection from general population or general hospital; B: only selected group of patients; C: no description of inclusion/exclusion criteria. 2. Selection of the non exposed cohort--N/A: not applicable. 3. Ascertainment of exposure--A: examination protocol or department's archive; B: no description. 4. Demonstration outcome of interest non present at start--A: yes; B: no. **B. Comparability** 1. Comparability of cohorts on the basis of the design or analysis--N/A: not applicable. **C. Outcome** 1. Assessment of outcome--A: independent physician's assessment record linkage; B: self-report or no description. 2. Adequacy of follow-up cohorts--A: yes ( ≥ 1 month); B: no ( \< 1 month). 3. Was follow-up long enough for outcomes to occur--A: complete follow up or B: minimal loss to follow up ( ≤ 20 %) all ages included, all diseases, or description of those lost suggesting no difference from those followed; B: follow-up rate \< 80 % and no description of losses to follow up or description suggesting differences from those followed or no statement. **Score: A = 1; B = 0.**

Discussion
==========

According to the NCCN guidelines, all suspected or histologically defined GISTs \> 2 cm and GISTs \< 2 cm that show high-risk EUS features shoud be surgically resected, due to their malignant potential [@JR1832-1] . Indeed, asymptomatic benign G-SMTs such as leiomyoma or lipomas may complicate (i. e. obstruction, bleeding or twisting) during tumoral growth. Finally, patients affected by suspected or defined GISTs \< 2 cm often refuse long-term endoscopic follow-up, strongly requiring definitive treatment and diagnosis. In this setting, laparoscopic resection is currently regarded as the gold standard [@JR1832-1] . However, in the last decade, the minimally invasive and scarless Eo-EFTR technique without laparoscopic assistance has emerged as a new therapeutic modality with promising efficacy and safety in the resection of MP-originating G-SMTs [@JR1832-2] [@JR1832-3] [@JR1832-4] [@JR1832-5] [@JR1832-6] . Worldwide application of Eo-EFTR to MP-originating G-SMTs has been partially limited by the technical difficulty involved and safety concerns, especially regarding effective defect closure achievement and potential peritoneal infection. In our opinion, the recent availability of endoscopic suturing devices could help in overhelming these concerns.

In the present systematic review, 750 G-SMTs of which 647 arising from the MP were treated by Eo-EFTR without laparoscopic assistance. Our systematic review showed that this NOTES technique is an effective procedure for removing deep G-SMTs, with an R0 resection being achieved in 98.8 % of the tumors. Despite the retrospective nature of all but one of the included studies, the strength and independence of the adopted reference standard (i. e. resection with negative margins at histological examination) may be expected to minimize the potential risk of recall bias. Indeed, no cases of tumor recurrence were reported in all but one included study providing follow-up.

Conversion to surgery due to either Eo-EFTR failure or AEs was needed in only 0.8 % of the procedures. Our analysis also showed an excellent safety profile for gastric Eo-EFTR without laparoscopic assistance. Overall major AEs (i. e. delayed bleeding, delayed perforation, peritonitis, abdominal abscess and/or abdominal infection) occurred in only 1.6 % of the cases, with peritonitis, abdominal abscess and/or abdominal infection being the most common major AEs (0.9 % of the procedures). Delayed bleeding and delayed perforation have been shown by our study to occur extremely rarely, in only 0.5 % and 0.1 % of the procedures, respectively. In our opinion, these findings could confirm the safety of the Eo-EFTR approach, especially with regard to potential infection of the sterile peritoneal cavity after gastric active perforation creation.

Finally, according to our analysis, a successful Eo-EFTR procedure, defined by complete resection of the tumor and effective defect closure with neither delayed perforation occurrence nor surgical conversion need, was achieved in 98.3 % of the cases.

This study has some notable limitations. First, with regard to study design, all but one of the included studies were retrospective, but they also embraced very long enrollment periods, thus variable learning-curve and post-training experience were likely to occur across the included studies. The follow-up period of recurrence also was not long enough and differed significantly. However, it did not affect the primary and secondary outcomes. Regarding Eo-EFTR feasibility, standardization of the procedure is poor and a wide variety of different cutting devices, accessories, countertraction and endoscopic closure techniques have been used. All of the included studies were from Asian countries with no western country contributions. Because of high heterogeneity among the selected studies, we did not conduct meta-analysis and performed qualitative integration in this systematic review

Conclusion
==========

In conclusion, this is the first systematic review providing information on the efficacy and safety profile of Eo-EFTR without laparoscopic assistance for removal of deep G-SMTs. Considering the high complete resection and overall successfull Eo-EFTR rates and the low major AE rates, Eo-EFTR without laparoscopic assistance appears to be an effective and safe minimally invasive treatment modality, at least in expert hands, for patients with deep G-SMTs. Better Eo-EFTR procedure standardization and a more widespread adoption in Western countries are required. Large prospective studies evaluating gastric Eo-EFTR are strongly desired.
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